![]() |
Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug Drug firm Indoco Remedies on Thursday said it has received approval from the US health regulator for Olanzapine tablets, indicated for the treatment of schizophrenia and bipolar disorder. Indoco Remedies Managing Director Aditi Kare Panandikar said this approval from the US health regulator will further supplement the solid dosage business for Indoco in the US. Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder. PTI | | New Delhi | Updated: 06-08-2020 10:38 IST | Created: 06-08-2020 10:38 IST |
|
|